The Tet 5-methylcytosine dioxygenases catalyze DNA demethylation by producing 5-hydroxymethylcytosine and further oxidized products. Tet1 and Tet2 are highly expressed in mouse pluripotent cells and downregulated to different extents in somatic cells, but the transcriptional mechanisms are unclear. Here we defined the promoter and enhancer domains in Tet1 and Tet2. Within a 15-kb "superenhancer" of Tet1, there are two transcription start sites (TSSs) with different activation patterns during development. A 6-kb promoter region upstream of the distal TSS is highly active in naive pluripotent cells, autonomously reports Tet1 expression in a transgenic system, and rapidly undergoes DNA methylation and silencing upon differentiation in cultured cells and native epiblast. A second TSS downstream, associated with a constitutively weak CpG-rich promoter, is activated by a neighboring enhancer in naive embryonic stem cells (ESCs) and primed epiblast-like cells (EpiLCs). Tet2 has a CpG island promoter with pluripotency-independent activity and an ESC-specific distal intragenic enhancer; the latter is rapidly downregulated in EpiLCs. Our study reveals distinct modes of transcriptional regulation at Tet1 and Tet2 during cell state transitions of early development. New transgenic reporters using Tet1 and Tet2 cis-regulatory domains may serve to distinguish nuanced changes in pluripotent states and the underlying epigenetic variations.
T
he study of transcription regulation is fundamental to understand how gene expression and phenotype are regulated during development. ENCODE (encyclopedia of DNA elements) studies recently revealed that the mammalian genome is more complex than previously annotated, in which different transcription start sites (TSSs) often mark core promoters, both intra-and intergenic, to drive the expression of alternative mRNA isoforms (1, 2) . Distal elements known as enhancers are often recruitment platforms for cell-type-specific transcription factors and interact with promoter-bound factors to stabilize the association of RNA polymerase II (Pol II) at TSSs (3) .
Embryonic stem cells (ESCs) derived from the inner cell mass (ICM) of mouse blastocysts represent a unique model of transcription regulation. The widespread presence of "open" chromatin achieved through feed-forward and autoregulatory loops involving transcription factors appears crucial for the transcriptome to adapt rapidly to inductive differentiation signals, allowing the cells to generate all early embryonic lineages (4, 5) . This pluripotent state is dependent on the master transcription factors Oct4, Sox2, and Nanog (OSN), which often bind cooperatively at target sites on enhancers. In early mammalian development, the triad of OSN, by binding to different enhancers, orchestrates two states of pluripotency, the "naive" and "primed" conditions resembling the pre-and postimplantation epiblasts, respectively (6, 7) . Furthermore, OSN together with Klf4, Esrrb, and Mediator coactivator, all highly expressed in naive ESCs, densely occupy extended domains of enhancer clusters, named "superenhancers," which are associated with genes that play major roles in ESC identity (8) . During differentiation, superenhancer-associated genes are highly sensitive to reduced Mediator occupancy and are rapidly silenced.
Among the list of superenhancer-associated genes in ESCs are Tet1 and Tet2, encoding DNA-modifying enzymes (8) . Together with Tet3, the TET dioxygenases act on 5-methylcytosine (5mC), the preeminent mark of DNA methylation in the mammalian genome, to generate 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxycytosine (5caC) (9) (10) (11) . The reiterative oxidation steps constitute both passive and active pathways in DNA demethylation; at the genome scale, this process is a fundamental part of epigenetic reprogramming (12) . Tet1 and Tet2 are highly expressed in mouse ESCs and primordial germ cells relative to somatic cells: both have been implicated in early embryonic differentiation (13, 14) , primordial germ cell specification (15, 16) , imprinting (17, 18) , and induced pluripotency (19, 20) .
In the adult, TET2 shows broader tissue-specific expression than does TET1 (21) . Tet3, although not part of the ESC gene signature, is expressed highly in many tissues, including oocytes, where it contributes to DNA hydroxymethylation in the paternal genome early postfertilization (22) . The loss of 5hmC and TET expression is also a hallmark of many cancers (23, 24) . Despite many studies on TET using loss-and gain-of-function approaches, the transcriptional mechanism underlying their tissue-specific expression remains to be clarified.
We previously showed that Tet1 and Tet2 expressions are dependent on Oct4 and Sox2 (13) . Using mouse-human sequence conservation to predict regulatory elements, we identified conserved Oct4 sites in Tet1 and Tet2. A subsequent study suggests that Oct4, but not Sox2, is required for Tet2 transcription by acting at the conserved Oct4-Sox2 motif (25) . In this study, we identified the TSS of Tet1 by 5= rapid amplification of cDNA ends (5= RACE). Using previously reported high-coverage chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-seq) data sets, we defined promoter and enhancer regions in Tet1 and Tet2, including additional elements in the superenhancer domains, and validated their cell state-specific activities by cell-based reporter assays. In addition, we examined the contribution of Oct4 and Sox2 motifs within the enhancer domains to transcription factor occupancy and gene expression. Finally, we examined DNA methylation changes at specific regulatory regions during early pluripotency states and differentiation.
MATERIALS AND METHODS
Cell culture. The mouse v6.5 ESC line (C57BL/6 ϫ 129/sv F1 hybrid) was cultured in standard ESC medium on feeder layer as previously described (13) . Cells were harvested by trypsin-EDTA treatment and replated twice on tissue culture wells over 30 to 45 min to remove the adherent feeders from the ESC in suspension. Culture in defined medium containing dual MEK and glycogen synthase kinase (GSK) inhibitors (2i medium and differentiation toward epiblast-like cells (EpiLCs) were performed as previously described (6) . The epiblast-derived stem cell (EpiSC) lines FT.1, FT.2, and FT.3 (26) were a generous gift from Alice Jouneau. NIH 3T3 (a kind gift from Francois Fuks) and HEK293T cells were cultured under standard conditions in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with GlutaMAX and 10% fetal bovine serum (FBS) (Sigma-Aldrich).
Mouse embryos and adult tissues. Embryos were isolated by mechanical dissection of the decidua isolated from the uterine lining of naturally mated C57BL/6 mice. Epiblasts from mice at embryonic day 6.0 postcoitum (E6.0) to E7.0 were extracted by first dissecting the embryos free of Reichert's membrane and peripheral trophectodermal tissues with the aid of fine tungsten needles. Next, the embryonic visceral endoderm was removed by incubating the embryos for 10 min at 4°C in 2.5% pancreatin-0.5% trypsin solution (in Ca 2ϩ /Mg 2ϩ -free Tyrode Ringer's saline). Finally, the epiblasts were separated from all other extraembryonic tissues. Each epiblast sample was pooled from 3 to 5 embryos for RNA or genomic DNA extraction. Embryos from E8.5 to E10.5 were dissected free of yolk sac and amnion. Mouse embryonic fibroblasts (MEFs) were derived from E13.5 mouse embryos and cultured for 2 to 3 passages before harvest. Adult tissues were dissected from 6-to 8-week-old female mice. All experimental procedures on mice have been reviewed and approved by the KU Leuven Ethical Committee for Animal Experimentation (P177/2011) in compliance with the European Directive 2010/63/EU. 5= rapid amplification of cDNA ends. Total RNA was isolated by using TRIzol for 5= RACE as according to the manufacturer's instructions (Invitrogen). Briefly, cDNA was synthesized with SuperScript II reverse transcriptase by using a gene-specific primer (see Table S1 in the supplemental material). A 3= homopolymeric cytosine or adenine tail was added by using terminal deoxynucleotidyltransferase (TdT) for PCR amplification. Purified PCR products were cloned into TOPO 2.1 (Invitrogen) for sequencing.
Quantitative reverse transcription-PCR (RT-PCR).
Total RNA was extracted from tissues following homogenization in TRIzol (Invitrogen) according to the manufacturer's instructions. RNA was purified from cells or from pooled epiblasts/individual embryos by using the RNeasy minikit or microkit, respectively (Qiagen), with on-column DNase I digestion. cDNA was synthesized by using SuperScript III (Invitrogen). Quantitative PCR (qPCR) was performed by using SYBR green PCR master mix (Invitrogen) on a StepOnePlus or ViiA7 real-time PCR system (Life Technologies). Absolute standard curves were generated by 10-fold serial dilutions of plasmid clones containing target sequences, starting from 10 5 or 10 6 copies estimated based on mass concentration. Transcript copy numbers were determined by calibration to standard curves and normalized by Gapdh gene copy numbers.
ChIP-seq analysis. ChIP-seq Sequence Read Archive (SRA) files were obtained from the GEO (see Table S2 in the supplemental material). Reads were aligned to mm9 by using the command line (-e 70 -k 1 -m 1 -n 2 -best -concise) on the software BowTie. Peaks were then identified by using MACS (model-based analysis of ChIP-seq) (66), using a two-sided comparison with input DNA when available, with default parameters (27) .
Reporter plasmid construction. Genomic fragments of Tet1 and Tet2 were amplified from the bacterial artificial chromosome (BAC) genomic clones RP23-132J10 and RP24-333H9, respectively, by using KOD DNA polymerase (Novagen). Primers for subcloning are listed in Table S1 in the supplemental material. Putative promoter fragments were subcloned into the pGL3-Basic vector (Promega) at either the MluI/XhoI or KpnI/ XhoI sites. Putative enhancer fragments were subcloned into the pGL-3-Promoter vector (Promega), containing a minimal simian virus 40 (SV40) promoter (or endogenous Tet1 and Tet2 promoter fragments), at the downstream SalI site in either the sense or antisense orientation to the luciferase gene (Luc). Methylated plasmids were generated in vitro by treating 10 to 18 g of plasmids with 80 U CpG methyltransferase M.SssI (New England BioLabs) in NEBuffer2 containing 640 M S-adenosylmethionine for 4 h at 37°C. Complete methylation was verified by protection against cleavage by HpaII and by bisulfite sequencing of promoter regions.
Site-directed mutagenesis. High-performance liquid chromatography (HPLC)-purified primers containing sequence modifications were used for PCR with KOD DNA polymerase (Novagen). The product was subjected to DpnI (Promega) treatment to digest the parental vector. The linear vector was gel purified, phosphorylated by using T4 polynucleotide kinase (Thermo Scientific), ligated by using T4 DNA polymerase (New England BioLabs), and transformed into competent bacteria. Modified fragments were verified by sequencing and further subcloned into the pGL3-Promoter vector(s).
Dual-Luciferase reporter assay. On the day of transfection, v6.5 ESCs were seeded at 1 ϫ 10 5 to 2 ϫ 10 5 cells per well of a 12-well plate containing feeder cells for transfection using Lipofectamine 2000 (Invitrogen). To transfect cells during the ESC-to-EpiLC conversion, 2i ESCs were seeded at 0.7 ϫ 10 5 to 1 ϫ 10 5 cells per well of a 12-well plate on day 0 in EpiLC differentiation medium and transfected as adherent cells on day 1; as controls, ESCs were seeded at similar densities in standard serum medium with leukemia inhibitory factor (LIF) on gelatin-coated plates and transfected in parallel. NIH 3T3 cells were seeded at 1 ϫ 10 5 to 2 ϫ 10 5 cells per well of a 6-well plate and transfected the next day as adherent cells by using TransIT-3T3 (Mirus Bio). All pGL3 constructs were cotransfected with pRL-TK at a ratio of 10:1 to normalize the transfection efficiency. Cells were harvested 2 days after transfection (or 36 h after the ESC-to-EpiLC conversion) for measurement of luciferase activities by using a Dual-Luciferase reporter assay system (Promega). Data are means Ϯ standard errors of the means (SEM) from at least 3 independent transfections, each performed in duplicate.
Electrophoretic mobility shift assay. Nuclear extracts (NEs) from ESCs or HEK293T cells were prepared from 2 ϫ 10 7 to 5 ϫ 10 7 cells, as previously described (28) . Oligonucleotides with 5= overhangs containing guanine(s) were hybridized, filled in with [␣-32 P]dCTP using Klenow fragments, and purified on a Sephadex column as labeled probes. A total of 5 to 10 g of the NE was incubated with the probe (20,000 cpm) on ice for 20 min in 1ϫ binding buffer (20 mM HEPES [pH 7.9], 0.1 mM EDTA, 5 mM MgCl 2 , 17% [vol/vol] glycerol, 100 mM NaCl) containing 50 ng/l poly(dI·dC) (Sigma-Aldrich), 20 mM dithiothreitol (DTT), and 1% Triton X. Supershift was performed by adding the antibodies for Sox2 (sc-17320) (28) and Oct4 (sc-5279) (Santa Cruz Biotech) to the NEs in binding buffer for 20 min, followed by the addition of labeled probe and incubation on ice for an additional 20 min. Similarly, unlabeled (cold) competitor duplex oligonucleotides were added at a 100ϫ to 300ϫ molar excess.
Bisulfite sequencing. Genomic DNAs were purified and bisulfite treated by using an EpiTect bisulfite conversion kit (Qiagen). Pooled epiblast specimens were processed by using the EpiTect Plus LyseAll bisulfite kit (Qiagen). Tet-assisted bisulfite (TAB) sequencing was performed by using the 5hmC TAB-Seq kit according to the manufacturer's protocol (WiseGene). PCR products were generated by using Hifi Taq polymerase (Invitrogen), gel purified, and subcloned into the pGEM-T Easy vector (Promega) for sequencing. The CpG methylation status of the sequences was analyzed using QUMA (67) . Samples with a conversion rate of Ͻ95% and a sequence identity of Ͻ90%, as well as identical bisulfite sequences, were excluded. Primers for bisulfite PCR are listed in Table S1 in the supplemental material.
Generation of a fluorescence reporter transgenic line. The pGmch2p construct was derived from the pGL3 vector by removal of the Luc gene between the HindIII and XbaI sites and replacement with a bicistronic cassette of mCherry and a puromycin resistance open reading frame (ORF) linked by a viral 2A peptide (mCherry-2A-PuR). Thirty micrograms of purified, NotI-linearized plasmid was electroporated into 1 ϫ 10 7 v6.5 ESCs at 320 V and 250 F by using a Gene Pulser XCell system (Bio-Rad). Electroporated cells were plated onto puromycin-resistant feeders and treated 24 h later with 1.5 g/ml puromycin for 7 to 10 days to select for resistant colonies. mCherry-positive clones were picked and propagated under standard ESC culture conditions. Cellular fluorescence was monitored and imaged with a Zeiss Axiovert 40 CFL microscope. Cell suspensions were collected for flow cytometry on a MACSQuant VYB instrument and analyzed by using FlowJo software.
Statistical analysis. The significance of mean differences was calculated by analysis of variance (ANOVA) and a multiple-comparison post hoc test using GraphPad Prism. P values of Ͻ0.05 were considered statistically significant. Accession numbers. Clonal sequences obtained by 5= RACE analyses of Tet1 as shown in Fig S1 in the supplemental material have been deposited at the European Nucleotide Archive under accession numbers LN810022 to LN810047 and are accessible on at www.ebi.ac.uk/ena/data /view/LN810022-LN810047. The NCBI Reference Sequence (RefSeq) number for the Tet1 mRNA transcript as shown in the UCSC genome browser is NM_001253857.1. The genome build of NCBI Mus musculus Annotation Release 104 contains additional mRNA reference sequences predicted by automated computational analysis: the 5= untranslated region (UTR) starting with exon 1b as described in this study matches sequences under accession numbers XM_006513873.1, XM_006513866.1, XM_006513868.1, and XR_380416.1; the 5= UTR starting with the exon 1a sequence as annotated in this study matches a sequence under accession number XM_006513867.1; a variant exon 1a sequence (found in 5= RACE clones 7 and 10 as shown in Fig. S1E ) matches the sequence under accession number XM_006513869.1.
RESULTS

Identification of two cell state-dependent TSSs in Tet1.
The NCBI reference murine Tet1 mRNA transcript lacks a 5= untranslated region (UTR). To determine the TSS of Tet1, we performed 5= RACE with mouse v6.5 ESCs (see Fig. S1 in the supplemental material). All sequenced clonal products had in common a 119-bp 5= UTR contiguous with the coding sequence (CDS), constituting exon 2, but spliced to different noncoding exons (exon 1) upstream. The majority (21 of 28 clones) of 5= ends aligned with a site 12.7 kb upstream of exon 2, here denoted exon 1b ( Fig. 1A ; see also Fig. S1 in the supplemental material). A few clones (4 of 28) mapped to a site 7.2 kb upstream, denoted exon 1a, which shares sequence similarity with noncoding exon 1 annotated in human TET1 (Fig. 1A) . The remaining clones (3 of 28) mapped to different sites further upstream of exon 1b but, as they were minor products, were not investigated further (see Fig. S1E in the supplemental material). Both exons 1a and 1b aligned with strong binding peaks of the initiating form of Pol II (Pol2_5P) in the mouse ESC genome (29) , consistent with both sites having TSSs. Binding peaks for the elongation form (Pol2_2P) suggest active transcription across the gene body downstream of exon 1a. Weak Pol II peaks were also detected in the vicinity of the Ensembl noncoding exon (ENSMUSE00000930068) located 18.8 kb upstream of the CDS, which we denote exon 1c (Fig. 1A) , although this transcript was never detected by 5= RACE.
To measure the relative abundance of these 5=-UTR transcript variants, we performed quantitative RT-PCR (qPCR) using a forward primer specific for each noncoding exon (exons 1a, 1b, and 1c) paired with a common reverse primer in exon 2 ( . Levels of expression of 5=-UTR variants were compared to that from a coding region (detected by using a primer pair specific for exons 12 and 13) in terms of transcript copy numbers. Based on these measurements, the TSS at exon 1b appeared to be the most active; transcript copy numbers detected at exon 1b exceeded those detected at the 3= coding region and those at exon 1a by 2-fold and 6-fold, respectively (2.1-Ϯ 0.3-fold and 6.0-Ϯ 0.8-fold) (n ϭ 6) (Fig. 1B) . Transcripts starting from exon 1c were hardly detectable (see Fig. S2C in the supplemental material). The greater abundance of 5=-end transcripts than of full-length copies suggests a steady-state level of transcriptional initiation exceeding elongation at the Tet1 TSS, which is indicative of regulation at the postinitiation step. A genome-wide analysis using human cells described transcription initiation at most genes, only a subset of which experiences elongation, as a general phenomenon (30) .
We observed simiilar transcript profiles for Tet1 in feeder-cultured mouse ESCs and induced pluripotent stem cells (iPSCs) (Fig. 1B) . To determine whether this profile reflects heterogeneity within ESC cultures, we compared feeder-free cultures of ESCs maintained with exogenous leukemia inhibitory factor (LIF) in the presence of serum (serum ESCs) and in defined "2i" medium (2i ESCs); the latter condition is thought to promote a more homogeneous population of naive cells in a "ground" state of pluripotency (31) . The depletion of feeders from v6.5 cells resulted in a 2-to 3-fold diminution in the overall level of Tet1 transcripts, associated with increased spontaneous differentiation, but the levels of exon 1b consistently exceeded those of exon 1a by 5-to 6-fold (5.5-Ϯ 0.5-fold) (n ϭ 3) and were comparable to the levels in the feeder-independent ESC lines CJ7 and E14Tg2a grown in serum ( Fig. 1C ; see also Fig. S2D in the supplemental material). Culture in 2i, which sustains cells as undifferentiated rounded colonies, caused a modest reduction in overall Tet1 expression levels compared to those in serum ESCs but retained the relative exon 1b/1a expression ratio of about 5 (4.8 Ϯ 0.7):1 (n ϭ 6) (Fig.  1C) . The latter finding is in agreement with previous studies describing modest or variable differences in Tet1 expression between 2i and serum conditions (32) (33) (34) . Although we cannot formally rule out that individual cells may selectively activate one TSS over the other without single-cell analysis, our results suggest that the two TSSs are more likely to be concurrently active in each cell.
To investigate further whether Tet1 expression changes during early postimplantation development, we used a recently reported protocol to differentiate 2i ESCs into epiblast-like cells (EpiLCs) in 48 h (35) . The converted EpiLCs displayed a gene expression profile similar to that of early, pre-primitive-streak stage postimplantation embryos, as previously described (6), representing a state of primed pluripotency (see Fig. S2E in the supplemental material). In EpiLCs, the Tet1 transcript profile remained similar to that in 2i ESCs, although the ratio of exon 1b/1a decreased to 3.3 Ϯ 0.5 (n ϭ 4). In contrast, mouse epiblast-derived stem cells (EpiSCs), which were recently shown to resemble the late-gastrula-stage epiblast/ectoderm upon in vitro adaptation (36) , showed an altered profile, in which exon 1a transcripts were sustained but exon 1b transcripts were further diminished to low levels (with a ratio of exon 1b to 1a transcripts of 0.3 Ϯ 0.1 to 1 n ϭ 3) (Fig. 1C) .
To correlate these observations with changes in vivo, we examined native epiblasts of E6.0 to E7.0 early gastrulating mouse embryos and whole embryos at E8.5 to E10.5 postgastrulation stages. In prestreak stage (E6.0) and early-streak stage (E6.5) mouse epiblasts, we observed the expression of exon 1a transcripts at ESC levels (3.7% Ϯ 0.3% of Gapdh levels; n ϭ 6) and already diminished levels of exon 1b transcripts (Ͻ1% of Gapdh levels) (Fig.  1D) . The difference between EpiLCs in vitro and E6.0 epiblasts in vivo suggests that EpiLCs may correlate more closely to the E5.0 to E5.5 epiblasts not examined in this study. Levels of exon 1a and 1b transcripts declined in mid-streak-stage (E7.0) embryos, becoming more similar to the transcript profile of EpiSCs. By E8.5, exon 1b was no longer detected in whole embryos. TSS at exon 1a sustained low levels of Tet1 expression in E8.5 to E10.5 embryos (0.3 to 1.6% of Gapdh levels) but was further downregulated in primary cultures of E13.5 mouse embryonic fibroblasts (Fig. 1D ). In the adult mouse, low levels of Tet1 (Ͻ1% of Gapdh levels) persisted in all tissues examined; of the three 5= transcript variants examined (exons 1a, 1b, and 1c), only exon 1a was detectable (Fig.  1E) . Slightly elevated levels of Tet1 coding transcripts were observed in tissues of the brain (cerebellum, cortex, and hippocampus), as previously described (37, 38) , and in the ovaries. Quantitations were similar using primers specific for either exons 4 and 5 or exons 12 and 13 (data not shown). However, in brain tissues and also in the heart, the exon 1a 5= transcripts consistently did not account for the higher copy numbers of transcripts detected in the coding region, suggesting that there are alternative 5= transcripts not detected by our 5=-RACE and qPCR assays (Fig. 1E ). 5= RACE performed by using mouse cerebellum cDNA confirmed only one TSS at exon 1a (data not shown). One possible explanation for this finding is that transcription initiation occurs in the dispersed mode over the promoter region upstream of exon 1a. Sequences of 5=-RACE clonal products in ESCs that aligned close to exon 1a (see Fig. S1E in the supplemental material) indeed suggest TSSs at variant positions within the 200-bp vicinity of the exon 1a sequence annotated in this study (see Fig. S1F in the supplemental material), some of which cannot be detected by our qPCR primers.
Collectively, these results suggest a strong preference for TSS at exon 1b of Tet1 in the preimplantation ICM and early epiblast, which rapidly switches to a preference for a TSS at exon 1a in the postimplantation epiblast. In late-postgastrula-stage embryos and in the adult soma, only the TSS at exon 1a is weakly active.
Cell state-specific coupling of promoter and enhancer domains in Tet1. To identify cis-regulatory elements in Tet1, we surveyed its epigenome in mouse ESCs using ChIP-seq data sets ( Fig. 2A ; see also Table S2 in the supplemental material). The combinatorial binding profiles of pluripotency factors, Mediator, and cohesin units have previously delineated a superenhancer domain in Tet1, a 15.2-kb region that spans from exon 1c at the distal end to a conserved noncoding sequence (CNS) upstream of the CDS (8) ( Fig. 2A ; see also Fig. S3 in the supplemental material). ChIP-seq showed strong binding profiles of Oct4 within the CNS, as previously shown (13), but also several more strong peaks in the distal region between exons 1b and 1c ( Fig. 2A) . We also examined specific chromatin signatures of histone H3 lysine 4 trimethylation (H3K4me3), which marks active promoters, and histone H3 lysine 4 monomethylation (H3K4me1) in combination with the presence of histone H3 lysine 27 acetylation (H3K27ac) and the absence of H3K4me3, which frequently marks active enhancers (39, 40) . Consistent with exons 1a and 1b having active TSSs, both sites were associated with strong and broad H3K4me3 marks ( Fig.  2A) . Signals for H3K4me1 were detected across the entire gene locus, but the signals for H3K27ac were highly enriched over a 22.9-kb region, which encompasses and extends upstream of the superenhancer. In ESCs, the gene locus is entirely devoid of signals for the silencing mark H3K27me3 (data not shown).
Based on these chromatin signatures and binding patterns of trans-acting factors, we defined two genomic segments as putative promoter regions: the 5-kb segment A and 6-kb segment B upstream of and including exons 1a and 1b, respectively. These segments were subcloned as 5=-serially deleted fragments upstream of a reporter gene ( Fig. 2A) . Segment B contains 6 prominent ChIPseq peaks that are common binding sites for OSN factors, p300, and Mediator (see Fig. S3 in the supplemental material); therefore, 6 subfragments were tested, which represent truncations to progressively remove each ChIP-seq peak region ( Fig. 2A) . The constructs were transfected into either mouse v6.5 ESCs or NIH 3T3 cells (a murine fibroblast line, as a nonpluripotent control) for in vitro reporter assays.
Within genomic region A, all 5 fragments of various lengths showed no promoter activity in ESCs and low basal activity in NIH 3T3 cells (see Fig. S4A in the supplemental material). In contrast, all fragments within segment B, except for the shortest 0.5-kb fragment, fragment B1, showed strong promoter activity in ESCs at least 10-fold (n ϭ 4 to 6) above basal levels observed for NIH 3T3 cells, suggesting that the promoter activity within region B is highly ESC specific (Fig. 2B) . The 3.4-kb fragment B4 (base positions Ϫ3242 to ϩ168 of TSS at exon 1b) consistently showed the strongest ESC-specific activity, significantly exceeding the activities of all other fragments in ESCs. Adjustment of the transfection ratios of plasmids to account for their different sizes had no apparent effect on their relative activity within the limits of the transfection conditions (see Fig. S4B in the supplemental material). To determine whether the differences were due to the presence of enhancer or repressor elements, we tested the individual 1-kb fragments D1 to D4, each compassing an OSN peak in region B for regulatory activity. In reporter constructs driven by either a minimal SV40 promoter or the endogenous Tet1 promoter (fragment B3), all D subfragments caused no effect or only a modest 2-to 3-fold increase in promoter activity (see Fig. S4C and D in the supplemental material). These experiments showed no evidence for any strong distal-acting enhancer or repressor constituents within the D fragments. Alternatively, these regions may function as cis regulators only in the context of the entire 6-kb promoter. Thus, we regard the entire 6-kb fragment B6 as a functionally autonomous full promoter. Fragment B1, with only one OSN peak region, may constitute a minimal proximal promoter.
We next tested the 1.4-kb fragment E, which compasses the CNS and an Oct-Sox (O/S) motif, for enhancer function (Fig. 2A) . In either orientation, fragment E increased SV40 promoter activity by 5-to 15-fold (n ϭ 5) in ESCs (significantly higher in the sense [Ͼ10-fold] than in the antisense [5-to 10-fold] direction) and not at all in NIH 3T3 cells, which is indicative of a highly ESC-specific enhancer (Fig. 2C) . We further examined the effect of fragment E cloned in the sense direction downstream of endogenous Tet1 promoter sequence A or B. Interestingly, fragment E activated sequence A fragments of various sizes, which all showed negligible promoter activity by themselves in vitro (see Fig. S4A in the supplemental material), in ESCs but not in NIH 3T3 cells (Fig.  2D and data not shown) . Fragment E enhanced the activity of fragment B1 by a variable 3.8-Ϯ 1.4-fold (n ϭ 4) but had no stimulatory effect on the full promoter B6 (Fig. 2D) . (Fig. 2E) . These results suggest two functionally autonomous domains within the Tet1 "superenhancer," each regulating a distinct TSS: (i) the distal 6.2-kb domain B, which appears to be sufficient to activate transcription at exon 1b at a high level, and (ii) the proximal 8.6-kb domain (spanning A and E), comprising a weak promoter at exon 1a and a proximal intragenic enhancer active in both the naive and primed pluripotent states.
A pluripotency-independent promoter coupled to an ESCspecific enhancer in Tet2. By 5= RACE of Tet2, we confirmed a dominant TSS at exon 1, 56 kb upstream of the annotated CDS, which aligns with ChIP-seq peaks for Pol2_5P in ESCs (see Fig.  S5A and S5B in the supplemental material). To define the functional promoter region, we examined a 6-kb genomic region upstream and inclusive of the 191-bp exon 1 (denoted sequence F) and subcloned 4 fragments serially truncated from the 5= end (Fig.  3A) . All four fragments showed high promoter activity in both ESCs and NIH 3T3 cells (Fig. 3B) . Although the promoter activity of each fragment was 2-to 4-fold (n ϭ 3 to 5) higher in ESCs than in NIH 3T3 cells, the normalized luciferase activities measured in NIH 3T3 cells were nonetheless substantial (50-fold above those of controls without the promoter), suggesting that the promoter can be functional in either pluripotent or nonpluripotent cells without additional cis-regulatory elements. The removal of segment F1 from the 3= ends of fragments F2 and F3 abolished all promoter activity in ESCs and NIH 3T3 cells (data not shown). These data suggest that the proximal promoter of Tet2 can be defined within a narrow locus of 556 bp surrounding the TSS, consistent with the high density of active H3K4me3 and H3K27ac ChIP-seq signals in this vicinity and the dearth of these signals upstream (Fig. 3A) .
We previously found an O/S motif within a CNS at base position ϩ1788 to ϩ1802 downstream of the Tet2 TSS; this locus (CNS1) was associated with weak Oct4 binding (13, 25) . Two distal intergenic CNS regions that contain putative O/S motifs, at kb Ϫ140 (CNS2) and kb Ϫ200 (CNS3) upstream (see Fig. S6A in the supplemental material), showed no detectable Oct4 binding but were subsequently described to be functional enhancers during B cell-to-macrophage trans differentiation (41). We tested enhancer activity in fragments flanking each O/S motif in the three CNS regions. None of them showed any enhancer activity (Ͻ2-fold increase of SV40 promoter activity; n ϭ 3) in ESCs (see Fig.  S6B in the supplemental material). We also examined a longer 2.5-kb intragenic region, fragment G, that overlaps the motif in CNS1 and the peaks for H3K4me1 and H3K27ac (Fig. 3A) . Fragment G was also devoid of enhancer activity in ESCs and NIH 3T3 cells (see Fig. S6C in the supplemental material).
To search for other possible ESC-specific Tet2 enhancer elements, we looked for ChIP-seq peaks elsewhere in the gene. The superenhancer cluster marked by prominent OSN peaks indeed lies further downstream in introns 1 and 2 (see Fig. S5C in the supplemental material). Based on these OSN locations, we examined 3 regions, regions H, I, and J (Fig. 3A) . The 2.8-kb region H showed strong ESC-specific enhancer activity (Ͼ10-fold above control levels; n ϭ 3); in contrast, regions I and J had weak or no activity (Ͻ3-fold; n ϭ 3 or 4) ( Fig. 3C; see also Fig. S6C in the supplemental material). By splitting region H into two 1.1-to 1.2-kb subfragments, fragments H1 and H2, each corresponding to an individual OSN peak, we further localized the ESC-specific enhancer within fragment H1 (Fig. 3C) . Similar enhancer activities (or the lack thereof) were observed for each fragment cloned in either orientation (see Fig. S6D in the supplemental material) . When cloned downstream of reporter constructs driven by the already strong promoter fragments F1 and F4, fragment H1 caused a further 3-to 4-fold increase in reporter activities (Fig.  3D ). In concert with the loss of Tet2 expression during the ESCto-EpiLC transition (see Fig. S2E in the supplemental material), the enhancer activity of fragment H1 was rapidly downregulated in EpiLCs compared to the levels in serum ESCs (Fig. 3E) . When enhancer effects on the same mammalian promoter (fragment A5) were compared, Tet2 enhancer H1 was inactivated, in contrast to the sustained activity of Tet1 enhancer E in EpiLCs (Fig. 3F) . Our results suggest that Tet2 is regulated by a pluripotency stateindependent promoter, but expression can be further increased in ESCs via a distal intragenic naive-state-specific enhancer.
Contribution of Oct and Sox motifs in Tet1 and Tet2 enhancer fragments. To determine whether the O/S motif in Tet1 fragment E (Fig. 4A ) binds Oct4 and/or Sox2 in vitro, we performed gel shift assays using a 48-bp DNA probe incubated with nuclear extracts from mouse ESCs or from HEK293T cells overexpressing OCT4 and/or SOX2 (Fig. 4B) . Two prominent bands of DNA-protein complexes were generated by ESCs and OCT4-expressing HEK293T cell extracts. The lower band was lost and "supershifted" by incubation with an Oct4-specific antibody, which is indicative of a specific DNA-Oct4 complex (Fig. 4B) . The higher band (Fig. 4B, asterisk) , produced by all nuclear extracts, likely contains the ubiquitously expressed Oct1 (42) . Incubation with nuclear extracts of HEK293T cells overexpressing SOX2 failed to produce any additional band that could be supershifted by a Sox2 antibody.
We further mutated the Oct4 motif as well as the adjacent 5= sequence that weakly resembles a Sox2 motif [C(A/T)TTGT] (Fig.  4A) (28) . In competition binding assays, the formation of complexes between the wild-type (wt)-labeled probe and nuclear extracts from ESCs and HEK293T cells expressing OCT4 and SOX2 was effectively abolished by cold wt and Sox motif-mutated (Sm) competitors but not by a cold Oct4 motif-mutated (Om) competitor probe ( Fig. 4C ; see also Fig. S7A in the supplemental material). We conclude that Oct4 binds directly to its cognate octamer element within fragment E, but in vitro Sox2 binding could not be detected under the conditions of our assay.
To test whether the Oct4 motif is functionally critical for enhancer activity, we first divided fragment E into two parts, in which the Oct4 motif was in the 3= portion. Surprisingly, the 5= half retained enhancer activity without the Oct4 motif, but the 3= half lost all stimulatory effects (Fig. 4D) . Mutation of the Oct4 motif within the full fragment E also did not abolish but instead increased enhancer activity, whereas mutation of the Sox2 motif had no significant effect (n ϭ 5) ( Fig. 4E ; see also Fig. S7B in the supplemental material). Thus, both deletion and mutation analyses showed that the Oct4 motif in fragment E, despite binding Oct4 in vitro, is dispensable for enhancer function.
The lack of enhancer function at the 3= end of fragment E prompted us to examine the 5= part for other putative elements. Indeed, we identified a sequence (CCTTTGT) resembling a Sox2 motif (Fig. 4F) . Using extracts from ESCs and HEK293T cells overexpressing SOX2, we observed complexes binding to a DNA probe containing the putative motif (labeled 5= Sox to distinguish from the 3= Sox-Oct motif shown in Fig. 4A ). The Sox2 antibody . Both cold wt and Sox motif mutant probes competed with the labeled probe, although the mutant probe was less effective than the wt, suggesting that Sox2 likely binds in vitro to sites other than its putative motif within the probe. Nonetheless, mutation and deletion of the 5= Sox motif significantly reduced the enhancer activity of fragment E on either the SV40 promoter or the endogenous Tet1 promoter A (fragment A5) by ϳ50% ( Fig.  4H ; see also Fig. S7B in the supplemental material) . Together, our results support that Sox2 binds at a different site (5=) from the Oct4 site (3=) within fragment E; however, binding is not fully specific to the Sox motif, consistent with a partial contribution of the motif to enhancer function. In addition to the Sox2 motif, a putative Nanog motif (GNNCATTNNC) (8) was found at the 5= end of fragment E (see Fig. S7D in the supplemental material) . Despite possible Nanog binding to a probe sequence containing the motif, mutation or deletion of the motif had no effect on fragment E enhancer activity (see Fig. S7B , E, and F in the supplemental material).
Tet2 enhancer fragment H1 harbors a putative Oct-Sox motif (Fig. 4I) . A probe containing this motif indeed formed complexes with ESC extracts in gel shift assays (Fig. 4J) . Incubation with an Oct4 antibody but not a Sox2 antibody produced a supershift. However, both cold Om and Sm probes competed with the labeled probe for binding, although competition by the Om probe appeared to be partial, suggesting that Oct4 binding can also be motif independent. Neither mutation nor deletion of the entire Oct-Sox motif affected fragment H1 enhancer activity in vitro (Fig. 4K) , suggesting that Oct4 may regulate the Tet2 enhancer in an motifindependent manner.
Cell type-dependent regulation of Tet1 by DNA methylation. Murine Tet1 exon 1a overlaps a CpG island typical of many mammalian promoters and thus is expected to contain the canonical TSS. A previously reported Tet1 ChIP-seq data set also demonstrated Tet1 binding at exon 1a (see Fig. S3 in the supplemental material), suggesting that Tet1 regulates its own promoter (43) . In contrast, exon 1b is associated with a distal CpG-poor region with low-level conservation (Ͻ50%) with the human genome. In luciferase assays, we noted that B fragments had low but detectable basal activity in NIH 3T3 cells (ϳ10% of ESC levels), which may be attributed to a core promoter activity (Fig. 2B) . However, Tet1 transcripts of exon 1b were not detected in mouse embryonic fibroblasts (MEFs) (Fig. 1D) . DNase I hypersensitivity site (DHS) profiles (44) revealed that chromatin accessibility in segment B is very high in ESCs, with individual DHS peaks corresponding to the OSN peaks, but is lost in NIH 3T3 cells (Fig. 5A) . Base-resolution whole-genome bisulfite sequencing (WGBS) maps (45) also revealed differential methylation between ESCs and neuronal progenitor (NP) cells within this region, which is indicative of promoter silencing during differentiation (Fig. 5A) . We therefore investigated whether there is epigenetic regulation at the promoter regions of Tet1 by DNA methylation.
We examined the methylation status at CpG sites within or flanking four of the DHS/OSN peaks (D1-to D4-bis denoting loci analyzed) by bisulfite sequencing. All four sites were unmethylated or methylated at low levels (Ͻ20%) in ESCs and completely unmethylated in 2i cultures (Fig. 5B and data not shown) . Methylation increased marginally in EpiLCs but reached high levels (Ͼ70%) in EpiSCs, MEFs, and adult tissues ( Fig. 5B ; see also Fig.  S8A in the supplemental material) . In native E6.0 to E7.0 epiblasts, the D1-bis site was already highly methylated, consistent with the diminished levels of exon 1b transcripts compared to those in ESCs and EpiLCs. Traditional bisulfite sequencing cannot discriminate between 5mC and 5hmC among "methylated" cytosines (46) . However, global 5hmC levels are very low relative to those of 5mC in murine fibroblasts (13, 38) . Moreover, Tet-assisted bisulfite sequencing (47) of selected methylated loci showed hardly any 5hmC (see Fig. S8B in the supplemental material). To confirm that methylation (and not hydroxymethylation) causes silencing of the promoter region B, we performed in vitro methylation of fragments B1 to B3, including an additional fragment containing the D1-bis site (fragment B2ϩD1-bis), in the reporter plasmids by using CpG methyltransferase. Transfection of the methylated plasmids containing all promoter B fragments resulted in markedly reduced levels of reporter activity compared to that in unmethylated plasmids, down to the basal levels driven by the minimal SV40 promoter, which was unaffected by methylation (Fig. 5D) . In fact, methylation of only 4 CpG sites in fragments B1 and B2, which are within an OSN ChIP-seq peak and the DHS most proximal to exon 1b ( Fig. 2A and 5A) , was sufficient to reduce reporter activity by 90%. Together, these results are reflective of a differentially methylated regulatory (DMR) domain within Tet1 promoter region B that regulates transcription from exon 1b. Consistent with dynamic developmental-stage-specific changes in DNA methylation confined mostly to CpG-poor regulatory regions (48) , these results emphasize the need for base resolution and a CpG density-unbiased approach to unravel new critical DMR domains at specific gene loci.
We also examined a region flanking the CpG island at exon 1a S8A in the supplemental material). In NIH 3T3 cells, the levels of methylation were higher in region A (28.9%) but lower in region B (represented by D1-to D4-bis) than those detected in MEFs, which is suggestive of aberrant de novo methylation at the CpG island and hypomethylation at CpG-poor sites unique to tumor transformation. DHS profiles also showed that this is one of few regions at the Tet1 locus, including one site ϳ6 kb downstream with a differential CCCTC binding factor (CTCF) binding pattern, that retains an open chromatin in both ESCs and NIH 3T3 cells (Fig. 5A ). An adjacent locus 5= of the CpG-poor enhancer E was methylated at low levels (Ͻ20%) in ESCs, EpiLCs, and E6.0 to E6.5 epiblasts; it gained intermediate methylation states (20 Fig. S8C in the supplemental material). Clonal bisulfite sequencing analysis of 33 of 115 CpG sites within the CpG island indeed revealed that this locus was completely unmethylated in ESCs, EpiLCs, EpiSCs, and MEFs, although there was a notable increase in methylation (to 37.9%) in NIH 3T3 cells (see Fig. S8D in the supplemental material). The intragenic enhancer region H1 was methylated at low levels in ESCs, EpiLCs, and E6.0 to E7.0 epiblasts (Ͻ15%) but was methylated at intermediate levels (30 to 50%) in EpiSCs and MEFs (see Fig. S8D and S8E in the supplemental material), suggesting that this enhancer may not be regulated by DNA methylation during exit from pluripotency.
We further investigated the dynamics of transcriptional and methylation changes at Tet1 during differentiation using an in vitro assay of LIF and feeder withdrawal and supplementation with all-trans retinoic acid (RA). As previously reported, Tet1 and Tet2 transcripts were rapidly downregulated concomitantly with Oct4 within 2 days of LIF withdrawal and RA induction (13) . We measured Tet1 transcript levels from exons 1a and 1b and coding regions during this time course by qPCR. Exogenous LIF sustained Tet1 expression for at least 3 to 4 days, although total transcript levels progressively decreased to 2 to 4% of Gapdh levels upon feeder-free adaptation (Fig. 6A) . Upon RA-induced differentiation, the expression of exon 1b rapidly diminished within 24 h and was undetectable by 2 days. In contrast, the expression of exon 1a persisted at lower levels in both LIF-cultured and differentiating cells (Fig. 6A) . Thus, the decline of total Tet1 levels during RA-induced differentiation is reflected by changes in exon 1b and not exon 1a transcripts.
Consistent with sustainable exon 1a expression, the CpG island region proximal to exon 1a stayed unmethylated during the entire differentiation time course (see Fig. S9A in the supplemental material). The downstream CTCF site also stayed methylated at similarly low levels (Ͻ40%) in both the LIF-sustained and RA-treated (in the absence of LIF) groups (see Fig. S9B in the supplemental material). Although the CTCF site stayed unmethylated during this early differentiation time course, it was methylated later in the somatic lineage (Fig. 5B) .
To track the methylation changes in genomic region B of Tet1, we focused on the two DMR sites D1-and D4-bis. In the presence of exogenous LIF, methylation levels at site D1 stayed low (Ͻ30%), at a level typical of feeder-free adapted ESCs grown in serum, and increased only marginally to 34.8% at day 3, along with increased spontaneous differentiation. Upon RA-induced differentiation, methylation exceeded 50% by 48 h and reached a high level of 70% by day 3 (Fig. 6B) . Overall, the kinetics of methylation gain at site D1-bis appeared to be tightly associated with the loss of exon 1b expression and further supports DNA methylation at this locus as a transcriptional silencing mark. In contrast, methylation of the D4 locus showed fewer differential changes during differentiation (Fig. 6C) . Under both LIF-supplemented and RA-induced differentiating conditions, site D4-bis progressively increased methylation to 50 to 60% during the first 2 days and displayed differential methylation only at day 3 (48.0% versus 80.0%). Thus, the methylation changes at site D4 did not correlate with transcript levels of exon 1b but may prime the region for silencing by differentiation cues. From these kinetics analyses of methylation changes at selected loci in Tet1, we infer that a wave of chromatin compaction progresses from the distal border toward the gene body during cellular differentiation but preserving a constitutive open region in the CpG island at exon 1a.
Sufficiency of Tet1 promoter domain B. To determine whether the 6-kb genomic segment B of Tet1 can function autonomously to mimic physiological patterns of gene expression, we placed fragment B6 upstream of the mCherry fluorescence reporter and stably introduced the construct into ESCs (Fig. 7A) . Two puromycin-resistant clones with bright fluorescence were selected for further analysis. Flow cytometry showed that Ͼ80% of cells from feeder cultures expressed the reporter, although all of them expressed high levels of the naive surface marker CD31 (Fig. 7B and data not shown; see also Fig. S10 in the supplemental material) . We speculate that ϳ20% of the cells from each clone may have undergone epigenetic silencing at the transgene during culture, even in the absence of spontaneous differentiation. When these clones were feeder depleted and induced to differentiate by using the same RA treatment as the one described above, fluorescence diminished in 2 days, similar to the kinetics of downregulation of the endogenous exon 1b transcripts ( Fig. 7C and D ; see also Fig. S10 in the supplemental material). Thus, our Tet1 fragment B6 transgenic reporter system faithfully mimics endogenous promoter activity, at least in vitro, and shows that the 6.2-kb promoter fragment B is sufficient to regulate transcription from exon 1b.
DISCUSSION
In this study, we defined two distinct TSSs in Tet1 and additional cis-regulatory elements in both Tet1 and Tet2 that account for their tissue-and development-stage expression patterns. The dynamic coupling of active promoter and enhancer domains in Tet1 causes a switch in dominant TSS usage during the transition from naive to primed pluripotent states, when expression from the gene-proximal TSS is sustained by a neighboring enhancer, and a further loss of expression in differentiated cells when both distal promoter and proximal enhancer regions are silenced. In contrast, Tet2 transcription is driven by a non-ESC-specific promoter, but high levels are sustained in naive ESCs by a distal intragenic enhancer that is rapidly inactivated in primed epiblast-like cells.
Our results account for the different tissue-specific expression patterns of Tet1 and Tet2 previously reported in the mouse (37, 38, 49) . Unlike in the mouse, TET1 levels remained stable during differentiation of human ESCs (14) . Our study resolves this discrepancy by demonstrating that postimplantation mouse epiblast and epiblast-derived stem cells, which share characteristics more similar to those of human ESCs (50), already lost the bulk of Tet1 expression via exon 1b and sustained Tet1 expression predominantly by using TSSs at exon 1a. Indeed, 5= RACE analysis of the H9 human ESC line confirmed that TET1 transcription starts from the annotated exon 1 homologous to exon 1a in the mouse (data not shown). Thus, the high Tet1 expression levels observed for mouse ESCs and iPSCs arise from the activation of a second promoter in the naive pluripotent state. Although not tested, we predict that high expression levels of Tet1 in primordial germ cells (15) are induced via strong transcription initiation from exon 1b. A recent study defined conditions to "reset" human ESCs to ground-state pluripotency, in which elevated TET1 expression was observed (51) . Whether an analogous alternative TSS and promoter region can be activated in naive-state human ESCs remains to be confirmed, but if indeed proven so, they will be valuable tools to discern truly naive-state human cells derived under alternative culture conditions. Recent methylome analyses revealed that mouse 2i ESCs develop a global hypomethylated state, associated with the suppression of Dnmt3a/Dnmt3b/Dnmt3L, which mimics the early ICM; in comparison, serum-cultured ESCs acquire de novo methylation and increased expression of Dnmt3b more typical of the epiblast in late blastocysts (32, 33) . Those studies analyzed feeder-free ESCs, and it is unclear how feeder-cultured ESCs correlate with the ICM. We consistently observed higher levels of Tet1 expression from both TSSs in feeder-cultured than in feeder-free ESCs. A previ- ously reported single-cell RNA sequencing analysis showed that ESCs (feeder cultured) are molecularly distinct from the E3.5 ICM and E4.5 epiblasts (52) and, by extrapolation, may also be distinct from feeder-depleted ESCs. Nonetheless, our results suggest that preimplantation development in the mouse involves higher Tet1 transcription levels, which are suppressed by the postimplantation stage. The transition from the preimplantation ICM (E3.5) to postimplantation epiblasts (E6.5) is associated with a global gain of DNA methylation (53) . The physiological function of Tet1 has been proposed to be that of a "maintenance" DNA demethylase to maintain the fidelity of DNA methylation patterns (54, 55) . Collectively, our results are consistent with a developmental model in which a burst of Tet1 transcription accompanies the upregulation of Dnmt3a/Dnmt3b in the transition from the early to late ICM to regulate de novo DNA methylation.
An epigenome comparison of naive ESCs and primed EpiSCs revealed the presence of "seed" enhancers, which are dormant in ESCs but activated in EpiSCs to take over primary transcriptional control of genes that are similarly expressed in either cell state (7) . By this definition, the proximal enhancer E of Tet1 is neither a seed nor a "poised" enhancer because total Tet1 RNA levels were much higher in ESCs than in EpiSCs; moreover, enhancer E demonstrated in vitro activity in both cell states (Fig. 2E) . Nonetheless, a striking analogy to the master pluripotency gene Oct4 can be drawn. The distal enhancer of Oct4, also the densest binding locus for key pluripotency transcription factors in ESCs (56), drives Oct4 expression in preimplantation embryos, primordial germ cells, and ESCs but not in postimplantation epiblasts, whereas the proximal enhancer directs postimplantation epiblast-specific expression (57).
Enhancers are classically described as position and orientation independent. Tet1 fragment E is unique in showing significantly higher enhancer activity when cloned in the sense than in the antisense direction in vitro. This is inconsistent with the model of transcription factor binding and activation in which recognition of cognate motifs can occur in either orientation (3). We speculate that there is an involvement of enhancer-associated noncoding RNA (ncRNA or eRNA), which is detectable by genomic run-on sequencing (GRO-seq) over the Tet1 superenhancer (see Fig. S3 in the supplemental material). The precise biological functions of these enhancer-like RNAs, which are transcribed bidirectionally, are only beginning to be understood, including a role in facilitating chromatin looping and transcription via an interaction with Mediator (58) . The presence of an SV40 late poly(A) signal in our luciferase construct in proximity to the enhancer cloning site may have interfered with ncRNA production in one direction. A previous study reported that Tet2 is regulated by Oct4 (25) . The authors of that study cloned a 2.4-kb genomic fragment, from base position Ϫ420 upstream of the TSS to base position ϩ1980 downstream in the intronic region encompassing the conserved O/S element in CNS1 (Tet2L) upstream of a reporter. By cotransfecting the reporter plasmid into NIH 3T3 cells with expression plasmids, those authors demonstrated that Oct4, but not Sox2, is necessary for Tet2 transcription (25) . In contrast, we showed that the minimal promoter region of Tet2 placed immediately upstream of the reporter gene is active in both pluripotent and nonpluripotent cells, even without the octamer element. Our results are consistent with the broad expression of Tet2 across tissue types in the soma by virtue of its pluripotency-independent promoter.
A previous analysis of ChIP-seq data from mouse ESCs (56) showed the binding of multiple pluripotency-associated transcription factors to a single cluster 12.5 to 22.3 kb upstream of the Tet1 gene, corresponding to genomic region B defined in this study (59) . However, an Oct4 site was lacking in this cluster. Here we used a more recent ChIP-seq data set (8) , which revealed similar binding sites within region B for many of these factors, including Oct4. Sequence analysis of the superenhancer region revealed only one O/S composite element in Tet1 region E. Here we validated that the composite motif indeed binds Oct4 (but not Sox2) directly in gel shift assays, consistent with the 100% match with the Oct4 consensus motif but a much weaker match for Sox2. Surprisingly, both composite Oct4-Sox2 motifs in Tet1 (fragment E) and Tet2 (fragment H1) enhancer fragments are not necessary for enhancer function. The lack of contribution by a motif in an in vitro luciferase reporter assay does not preclude a function in vivo in the native chromatin context. Nonetheless, our results support motif (sequence)-independent binding of transcription factors at high-occupancy target (HOT) regions (60, 61) .
By switching in vitro culture conditions of ESCs to mimic different states of embryonic development, together with analyses of early-postimplantation-stage epiblasts, we propose that the transition from pre-to postimplantation development involves a dramatic change in the transcriptional landscape at both the Tet1 and Tet2 gene loci so as to sustain Tet1 expression via TSSs at exon 1a but rapidly downregulate Tet2 in the postimplantation, prestreak epiblast. In view of the very low levels of Tet2 and Tet3 expression in the pre-and early-streak mouse epiblasts, Tet1 appears to be the predominant 5-methylcytosine oxygenase expressed at these stages (R. Khoueiry and K. P. Koh, unpublished data). In contrast to the pluripotency genes Oct4 and Nanog, Tet1 levels may decline rapidly during differentiation but are not completely silenced. The presence of a non-cell type-selective, albeit weak, promoter at exon 1a would contribute to low-level Oct4-independent expression of Tet1 in the postgastrulation embryo and adult soma, particularly in the brain (62, 63) . Full functional validation of the cis-regulatory elements described in this study will require further studies to remove specific sequences in cells and in transgenic mice. The precise physiological relevance of Tet1 expression in the early embryo also warrants further investigation by using strategies to abolish gene expression completely in the mouse.
Recent studies support a role of Tet1 and Tet2 in epigenetic reprogramming by facilitating DNA demethylation of Oct4 and other genes; Tet1 can even replace Oct4 in the classical 4-factor cocktail (64) . Many studies have relied on Oct4-green fluorescent protein (GFP) and Nanog-GFP reporters to select iPSCs. New transgenic reporters based on Tet1 and Tet2 will be valuable tools to unravel the mechanisms of their gene activation during reprogramming and ultimately provide insights into the acquisition of different induced pluripotent states and epigenetic memory.
